Journal
CANCER INVESTIGATION
Volume 27, Issue 7, Pages 802-808Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/07357900802672720
Keywords
Glioma; Apoptosis; Tamoxifen; PKC; ERK1; 2; Signal transduction
Categories
Funding
- Weis Center for Research, Geisinger Health System, Danville, PA 17822, USA
Ask authors/readers for more resources
Data have shown that tamoxifen (TAM) can be used to treat not only breast cancer with positive estrogen receptor (ER), but also negative ER including human glioma. However, the molecular mechanism of this drug against different kinds of cancers remains to be elucidated. In this study, we provided the evidence that PKC-ERK1/2 signaling pathway plays a negative role in TAM-induced C6 cell apoptosis, and a combined utilization of TAM with inhibitors of PKC or ERK1/2 could enhance the effectiveness of TAM on inhibiting tumor growth.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available